Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil.
Hospital Moinhos de Vento, Divisão de Nefrologia, Porto Alegre, RS, Brasil.
J Bras Nefrol. 2021 Apr-Jun;43(2):288-292. doi: 10.1590/2175-8239-JBN-2020-0044.
Cosmetic injections of fillers are common plastic surgery procedures worldwide. Polymethylmethacrylate (PMMA) is a filler approved only for minimally invasive procedures in facial tissue and is among the most frequently used injectable substances for cosmetic purposes. Injection of a large volume of PMMA may lead to the development of severe hypercalcemia and chronic kidney damage in a probably underestimated frequency. In such cases, hypercalcemia develops due to a granulomatous foreign body reaction with extrarenal production of calcitriol. In the present report, we describe the cases of two patients who received injections of large volumes of PMMA and developed severe hypercalcemia and advanced chronic kidney disease. These reports highlight the importance of adhering to regulations regarding the use of PMMA and properly informing patients of the possibility of complications before undertaking such procedures.
美容注射填充物是全球常见的整形手术。聚甲基丙烯酸甲酯(PMMA)仅被批准用于面部组织的微创程序,是最常用于美容目的的注射物质之一。大量注射 PMMA 可能会导致严重高钙血症和慢性肾脏损害,其发生频率可能被低估。在这种情况下,高钙血症是由于肉芽肿性异物反应引起的,这种反应会导致肾外产生骨化三醇。在本报告中,我们描述了两例接受大量 PMMA 注射后发生严重高钙血症和晚期慢性肾脏病的患者。这些报告强调了遵守有关 PMMA 使用的规定并在进行此类程序之前向患者告知并发症可能性的重要性。